Palbace (Palbociclib) 100mg | 21 Capsules
Palbace Drug Description
Drug Class and Categories: Palbace is classified as a CDK4/6 inhibitor and falls under the oncology and antineoplastic agent categories. It is primarily used in the treatment of hormone receptor-positive breast cancer.
Active Ingredient and Other Names:
-
Active Ingredient: Palbociclib
-
Popular and Other Names:
-
Brand Name: Palbace
-
Chemical Name: Palbociclib
-
Alternate Names: PD 0332991, Ibrance (brand name for Palbociclib)
-
Mode of Action: Palbace (Palbociclib) functions by inhibiting cyclin-dependent kinase 4 (CDK4) and cyclin-dependent kinase 6 (CDK6), which are essential for cell cycle progression. By blocking these enzymes, Palbace disrupts the proliferation of cancer cells, particularly those in hormone receptor-positive breast cancer. This mechanism helps to slow down or halt tumor growth and prevent cancer from spreading.
How to Use It:
-
Administration: Palbace is administered orally in tablet form.
-
Usage: Take the tablets by mouth with or without food, according to the dosage prescribed by your healthcare provider.
Recommended Dosage:
-
Standard Dosage: Typically, the dosage is 125 mg taken once daily for 21 days, followed by a 7-day break to complete a 28-day treatment cycle.
-
Dosage Adjustments: Dosage may be adjusted based on individual tolerance, side effects, and blood test results. Always follow the healthcare provider's instructions for any dosage changes.
Directions:
-
Administration: Swallow the tablets whole with a glass of water. Do not crush, chew, or split the tablets.
-
Missed Dose: If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. Do not double the dose to make up for a missed one.
Cautions:
-
Pregnancy and Breastfeeding: Avoid using Palbace during pregnancy and breastfeeding. Consult with your healthcare provider about potential risks and alternative treatments.
-
Pre-existing Conditions: Inform your healthcare provider of any liver disorders, infections, or blood disorders before starting Palbace.
-
Drug Interactions: Be aware of potential interactions with other medications. Provide a complete list of all drugs, vitamins, and supplements you are taking to your healthcare provider.
Manage Side Effects:
-
Common Side Effects: Nausea, fatigue, loss of appetite, diarrhea, and mouth sores are commonly reported.
-
Severe Side Effects: Monitor for severe infections, low blood cell counts, or liver problems. Contact your healthcare provider if you experience symptoms such as fever, unusual bleeding, or jaundice.
Guidelines:
-
Storage: Store Palbace at room temperature, away from moisture and heat. Keep it in its original container and out of reach of children.
-
Monitoring: Regular blood tests may be required to monitor blood cell counts and liver function throughout the treatment period.
-
Overdose: In case of an overdose, seek immediate medical help. Symptoms may include severe nausea, vomiting, or unusual bleeding.
Frequently Asked Questions (FAQs):
-
What is Palbace used for?
Palbace (Palbociclib) is used to treat hormone receptor-positive breast cancer, often in combination with other hormonal therapies. -
How should Palbace be taken?
Palbace is taken orally in tablet form, usually once daily for 21 days, followed by a 7-day break in a 28-day cycle. Follow your healthcare provider’s instructions for usage. -
What are the common side effects of Palbace?
Common side effects include nausea, fatigue, decreased appetite, diarrhea, and mouth sores. -
What should I do if I miss a dose of Palbace?
If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Avoid taking two doses at once. -
Are there any precautions I should take while using Palbace?
Yes, avoid Palbace during pregnancy and breastfeeding, and inform your healthcare provider of any liver conditions or drug interactions. -
Can Palbace be used with other treatments?
Palbace is often used in combination with other hormonal therapies for enhanced effectiveness in treating hormone receptor-positive breast cancer.